Innate Pharma"s stock rallies 23% on leukemia drug submission in Europe
Shares of Innate Pharma SA gained 23% in premarket trading on Thursday after the biotechnology company said the European Medici.....»»
Pharma Stock Roundup: JNJ & NVS" Q2 Earnings, FDA Approvals
J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»
Merck Wins Yet Again With New Keytruda Approval
Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The firm announced that the U.S. Food and Drug Administration (FDA) has approved........»»
Cocrystal stock doubles on massive volume a day after progress announced on coronavirus drug candidates
Shares of Cocrystal Pharma Inc. more than doubled on massive record volume in afternoon trading Tuesday, a day after the biotechnology company said it has made "progress" in developing antiviral .....»»
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) read more.....»»
Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut
Merck & Co., Inc. (NYSE: MRK) shares came under pressure in Tuesday's session after the pharma company lowered its .....»»
Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut
Merck & Co., Inc. (NYSE: MRK) shares came under pressure in Tuesday's session after the pharma company lowered its full-year guidance. The Merck Analysts Cantor Fitzgerald .....»»
Penny Stock Surges On In-Licensing Antiviral Drug Platform
Shares of nano-cap biotech Aikido Pharma Inc (NASDAQ: AIKI), are ripping higher following an announcement concerning worldwide licensing of an antiviral platform. read more.....»»
Food News Roundup: Guy Fieri Lends A Helping Hand, Expert Cautions Against Protectionist Measures, Coca-Cola Stock In Focus
The partnership between The National Restaurant Association's Education Foundation and "Diners, Drive-Ins and Dives" host and celebrity chef Guy Fieri went live on April 2 and crashed within minutes due to high levels of interest. read more.....»»
Philadelphia-based management team gives cannabis company a new focus
FSD Pharma is 'doubling down' on its drug development efforts......»»
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark"s COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) read more.....»»
Nanocap Biotech Stock Rips 180% Higher On Coronavirus Drug Licensing
Cocrystal Pharma Inc (NASDAQ: COCP) shares are skyrocketing Monday following a licensing agreement the company reached with the Kansas State University Research Foundation. read more.....»»
Merck’s spinoff plans place a big bet on cancer-fighting Keytruda
Merck stock fell on news it will spin off slow-growth areas to focus on Keytruda, its anti-cancer.....»»
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN) Aptose Biosciences .....»»